Aptevo Therapeutics Inc. buy marge
Start price
19.11.20
/
50%
€42.00
Target price
19.11.21
€50.00
Performance (%)
-67.07%
End price
07.11.21
€13.83
Summary
This prediction ended on 07.11.21 with a price of €13.83. The BUY prediction by marge for Aptevo Therapeutics Inc. performed very badly with a performance of -67.07%. marge has 50% into this predictionUnfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aptevo Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
According to marge what are the pros and cons of Aptevo Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year